Clinical trial
Cetuximab and Radiation Therapy for Surgically Resectable Esophageal and…
NCT00319735 · Nasser Hanna, M.D., Other · Completed
Key facts
| NCT number | NCT00319735 |
|---|---|
| Title | Cetuximab and Radiation Therapy for Surgically Resectable Esophageal and Gastroesophageal (GE) Junction Carcinomas |
| Official title | A Pilot Study With Cetuximab and Radiation Therapy for Patients With Surgically Resectable Esophageal and GE Junction Carcinomas: Hoosier Oncology Group Study (GI05-92) |
| Lead sponsor | Nasser Hanna, M.D., Other |
| Collaborators | Bristol-Myers Squibb Industry Walther Cancer Institute |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Esophageal Cancer |
| Intervention type | Procedure |
| Interventions | Radiation Therapy, Surgery, Tissue Sample |
| Enrollment | 41 |
| Start date | Apr 1, 2006 |
| Primary completion | Jan 1, 2009 |
| Completion | Jan 1, 2009 |
| First posted | Apr 27, 2006 |
| Last update posted | Apr 28, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: